The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production

[1]  Ji-Hye Park,et al.  Effects of exercise on glycemic control in type 2 diabetes mellitus in Koreans: the fifth Korea National Health and Nutrition Examination Survey (KNHANES V) , 2015, Journal of physical therapy science.

[2]  J. Ribeiro,et al.  Effects of l-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes , 2013, European Journal of Nutrition.

[3]  C. Boreham,et al.  Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study. , 2012, Metabolism: clinical and experimental.

[4]  G. Comi,et al.  Effect of a long‐term oral l‐arginine supplementation on glucose metabolism: a randomized, double‐blind, placebo‐controlled trial , 2012, Diabetes, obesity & metabolism.

[5]  Aline Bittencourt,et al.  Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets. , 2012, The Journal of endocrinology.

[6]  R. Curi,et al.  Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids. , 2012, The Journal of endocrinology.

[7]  P. Newsholme,et al.  Nutritional regulation of insulin secretion: implications for diabetes. , 2012, The Clinical biochemist. Reviews.

[8]  C. Boreham,et al.  Exercise Prescription in the Treatment of Type 2 Diabetes Mellitus , 2012, Sports Medicine.

[9]  P. Newsholme,et al.  L-arginine is essential for pancreatic β-cell functional integrity, metabolism and defense from inflammatory challenge. , 2011, The Journal of endocrinology.

[10]  C. Antoniades,et al.  Adiponectin as a regulator of vascular redox state: therapeutic implications. , 2011, Recent patents on cardiovascular drug discovery.

[11]  L. C. V. van Loon,et al.  Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients. , 2010, Diabetes research and clinical practice.

[12]  H. Degens,et al.  The role of systemic inflammation in age‐related muscle weakness and wasting , 2010, Scandinavian journal of medicine & science in sports.

[13]  P. Newsholme,et al.  Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. , 2010, Clinical science.

[14]  L. C. V. van Loon,et al.  Exercise therapy in Type 2 diabetes , 2009, Acta Diabetologica.

[15]  W. James,et al.  WHO recognition of the global obesity epidemic , 2008, International Journal of Obesity.

[16]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[17]  C. Lambert,et al.  Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. , 2008, Journal of applied physiology.

[18]  A. Rissanen,et al.  Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. , 2008, European journal of endocrinology.

[19]  J. Paul Robinson,et al.  The influence of exercise training on inflammatory cytokines and C-reactive protein. , 2007, Medicine and science in sports and exercise.

[20]  J. Brun,et al.  Réentraînement des maladies métaboliques ciblé individuellement par la calorimétrie d'effort , 2007 .

[21]  J. Brun,et al.  Metabolic training: new paradigms of exercise training for metabolic diseases with exercise calorimetry targeting individuals. , 2007, Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique.

[22]  V. Baldissera,et al.  Lactate and ventilatory thresholds in type 2 diabetic women. , 2007, Diabetes research and clinical practice.

[23]  A. Sastry,et al.  Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. , 2007, Endocrinology.

[24]  R. Curi,et al.  MRP1/GS‐X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress‐induced redox imbalance in comparison to skeletal muscle cells? , 2007, Cell biochemistry and function.

[25]  J. Brun,et al.  Substrate oxidation during exercise: type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization. , 2006, Diabetes & metabolism.

[26]  R. DeFronzo,et al.  Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases , 2006, Diabetes/metabolism research and reviews.

[27]  K. Sahlin,et al.  Maximal fat oxidation rates in endurance trained and untrained women , 2006, European Journal of Applied Physiology.

[28]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[29]  G A Naughton,et al.  Exercise for type 2 diabetes mellitus. , 2006, The Cochrane database of systematic reviews.

[30]  N. Wareham,et al.  Population impact of strategies for identifying groups at high risk of type 2 diabetes. , 2006, Preventive medicine.

[31]  G. Duncan.  Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome , 2006, Current diabetes reports.

[32]  W. Saris,et al.  Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery , 2006, Diabetologia.

[33]  F. Maltais,et al.  Skeletal muscle microbiopsy: a validation study of a minimally invasive technique , 2005, European Respiratory Journal.

[34]  A. Jeukendrup,et al.  Determinants of fat oxidation during exercise in healthy men and women: a cross-sectional study. , 2005, Journal of applied physiology.

[35]  D. Leroith,et al.  Skeletal muscle. , 2005, Advances in experimental medicine and biology.

[36]  Janos Porszasz,et al.  A treadmill ramp protocol using simultaneous changes in speed and grade. , 2003, Medicine and science in sports and exercise.

[37]  C. Mantzoros,et al.  Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. , 2003, Obesity research.

[38]  L. Ji.  Exercise‐induced Modulation of Antioxidant Defense , 2002, Annals of the New York Academy of Sciences.

[39]  E. Sato,et al.  [Reactive oxygen]. , 2002, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[40]  A. Jeukendrup,et al.  Determination of the exercise intensity that elicits maximal fat oxidation. , 2002, Medicine and science in sports and exercise.

[41]  R. Sigal,et al.  Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.

[42]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[43]  Glen P. Kenny,et al.  Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials , 2001 .

[44]  D. Meeking,et al.  Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. , 2000, Diabetes care.

[45]  V. Noonan,et al.  Submaximal exercise testing: clinical application and interpretation. , 2000, Physical therapy.

[46]  F. Péronnet,et al.  Table of nonprotein respiratory quotient: an update. , 1991, Canadian journal of sport sciences = Journal canadien des sciences du sport.

[47]  A. Kanamori,et al.  Relationship between age-adjusted heart rate and anaerobic threshold in estimating exercise intensity in diabetics. , 1990, Diabetes research and clinical practice.

[48]  R. Casaburi,et al.  Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination. , 1988, Chest.

[49]  M A Traill,et al.  Estimation of the concentration of low density lipoprotein cholesterol and very low density lipoprotein cholesterol by selective adsorption from serum with magnesium compounds. , 1973, Laboratory practice.

[50]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.